New York Pharma Forum elects new president
This article was originally published in Scrip
Executive Summary
The New York Pharma Forum, a US association of biopharmaceutical companies with a focus on Japan, has elected Dr Sapan Shah as president, effective immediately. Dr Shah, who is president and CEO of Shionogi's US subsidiary and was formerly vice-president of the forum, succeeds Dr Kenji Arima of Asubio Pharmaceuticals in the US, who is returning to Japan. The non-profit group organises networking and educational events on various issues for industry and other members and was set up around 20 years ago.